UK Markets close in 4 hrs 41 mins

Merck Kommanditgesellschaft auf Aktien (MKGAF)


Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
116.00-0.49 (-0.42%)
At close: 9:30AM EDT
People also watch
MKGAYESALYALIOFHENKYTKPYY
Full screen
Previous close116.49
Open0.00
Bid0.00 x
Ask0.00 x
Day's range0.00 - 0.00
52-week range
Volume0
Avg. volume177
Market cap49.02B
BetaN/A
PE ratio (TTM)28.27
EPS (TTM)4.1
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • PR Newswire3 days ago

    EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

    DARMSTADT, Germany and NEW YORK , July 20, 2017 /PRNewswire/ -- Not intended for UK-based media     If approved,   avelumab   could   be   the   first   immunotherapy   treatment   indicated   for   this ...

  • EU charges Merck KGaA, GE, Canon over merger rules
    Reuters18 days ago

    EU charges Merck KGaA, GE, Canon over merger rules

    General Electric (GE.N), German drugmaker Merck KGaA (MRCG.DE), and Japan's Canon (7751.T) risk hefty fines after EU antitrust regulators accused them of providing misleading information during separate merger deals. The European Commission said on Thursday that it had sent three separate charge sheets known as statements of objections to General Electric, Merck KGaA and Canon after investigations showed breaches of the bloc's merger rules. While the charges will not affect the EU approvals of the deals, they could lead to fines of up to 1 percent of global revenue for Merck KGaA and General Electric, and up to 10 percent for Canon.

  • Reuters18 days ago

    EU charges Merck KGaA, GE, Canon over merger rules

    General Electric, German drugmaker Merck KGaA, and Japan's Canon risk hefty fines after EU antitrust regulators accused them of providing misleading information during separate merger deals. The European Commission said on Thursday that it had sent three separate charge sheets known as statements of objections to General Electric, Merck KGaA and Canon after investigations showed breaches of the bloc's merger rules. While the charges will not affect the EU approvals of the deals, they could lead to fines of up to 1 percent of global revenue for Merck KGaA and General Electric, and up to 10 percent for Canon.